BMS-538203
CAS No. 543730-41-2
BMS-538203 ( BMS538203;BMS 538203 )
Catalog No. M14950 CAS No. 543730-41-2
A chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1053 | Get Quote |
|
50MG | 2142 | Get Quote |
|
100MG | 2790 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS-538203
-
NoteResearch use only, not for human use.
-
Brief DescriptionA chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
-
DescriptionA chemical intermidate of BMS-626529, a HIV-1 attachment inhibitor that targets gp120,
-
SynonymsBMS538203;BMS 538203
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number543730-41-2
-
Formula Weight269.23
-
Molecular FormulaC12H12FNO5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 54 mg/mL
-
SMILESO=C(O)/C(O)=C/C(N(CC1=CC=C(F)C=C1)OC)=O
-
Chemical Name2-Butenoic acid, 4-[[(4-fluorophenyl)methyl]methoxyamino]-2-hydroxy-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nowicka-Sans B, et al. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.
molnova catalog
related products
-
HIV-1 Integrase Inhi...
A novel compound that disrupts the HIV-1 integrase LEDGF interaction.
-
Reverse transcriptas...
Reverse transcriptase-IN-1 is a diarylbenzopyrimidine (DABP) analogue and a potent inhibitor of HIV-1 nonnucleoside reverse transcriptase with an IC50of 13.7 nM.
-
HIV p17 Gag 77-85
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.